There are many good reasons for your organisation to completely or partially outsource research on a contract basis, i.e., contract research. Collaborating with the Amsterdam research landscape not only saves time and reduces costs, your company will also benefit enormously by gaining access to specialised knowledge or expertise, and cutting-edge facilities. For instance:
Continue reading after the photo.
Successful collaborations start with good agreements. In contract research and contract manufacturing, you determine together with the researcher what is to be expected in terms of output (data, materials, inventories, reports etc.) and standards (quality standards etc.). Besides discussing which joint efforts are needed to deliver the required outcomes, financial and legal matters have to be tackled, such as fees, intellectual property rights and ownership on application.
IXA’s legal experts and business developers provide support and advice in the negotiations and in drafting public-private partnership contracts. These contracts will be fine-tuned to the particular nature of the activities and the needs and interests of the parties involved.
The project ChloroSpec, initiated by Alfred Holzwarth and Roberta Croce, establishes as BV. Lead by Peter Kievit (serial entrepreneur), ChloroSpec is a developer of plant health and stress analysis systems. ChloroSpec has developed a new technology that should become the gold standard in chlorophyll fluorescence monitoring of plants and algae, and analyzes how plants respond […]News
Dr. Ronald van Steden enters into a partnership with the Dutch police. Together they are committed to guide and monitor the new position of ‘director care and safety’ (regisseur zorg en veiligheid) in Amsterdam. Dr. Ronald van Steden, Associate Professor of Public Administration at the Vrije Universiteit Amsterdam and Senior Researcher at the NSCR, has […]News
A small fragment of a llama antibody, also called ‘nanobody’, is capable of reducing human cytomegalovirus (HCMV) in patients, scientists at the Vrije Universiteit and University of Cambridge found in a study. This could lower CMV-associated diseases and mortality during life-saving solid organ and stem cell transplantation and could be a potential lifesaving drug. HCMV […]News